Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shang Luo, Hua Man, Xile Jia, Yuanyuan Li, Aihong Pan, Xuecheng Zhang & Yimin Song. (2018) Preparation and characterization of acetylsalicylic acid/chitosan nanoparticles and its antithrombotic effects. Designed Monomers and Polymers 21:1, pages 172-181.
Read now
Read now
Flavia Temperilli, Aldona Rina, Isabella Massimi, Anna Lisa Montemari, Maria Luisa Guarino, Alessandra Zicari & Fabio M. Pulcinelli. (2015) Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. Platelets 26:8, pages 783-787.
Read now
Read now
Stavros Apostolakis, Gregory YH Lip & Eduard Shantsila. (2013) Pharmacokinetic considerations for antithrombotic therapies in stroke. Expert Opinion on Drug Metabolism & Toxicology 9:10, pages 1335-1347.
Read now
Read now
Nadzeya Kuzniatsova, Eduard Shantsila, Andrew Blann & Gregory Y. H. Lip. (2012) A contemporary viewpoint on ‘aspirin resistance’. Annals of Medicine 44:8, pages 773-783.
Read now
Read now
Sabrina Uhry, Jacques Bessereau, Laurence Camoin-Jau, Franck Paganelli & Laurent Bonello. (2012) Latest Evidence in Personalized Antiplatelet Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Hospital Practice 40:2, pages 104-117.
Read now
Read now
Norbert Zimmermann, Muhammed Kurt, Joachim Winter, Emmeran Gams, Folker Wenzel, Artur Aron Weber & Thomas Hohlfeld. (2007) Aspirin-induced platelet inhibition in patients undergoing cardiac surgery. Platelets 18:7, pages 528-534.
Read now
Read now
Artur-Aron Weber, Hans-Karl Heim, Marc Schumacher, Karsten Schrör & Thomas Hohlfeld. (2007) Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers. Platelets 18:5, pages 379-385.
Read now
Read now
Thomas Neuhaus, Simone Voit, Gereon Lill, Hans Vetter, Karsten Schrör & Artur-Aron Weber. (2004) Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 (4N1-1) is inhibited by epigallocatechin gallate but not by prostaglandin E1. Platelets 15:7, pages 455-457.
Read now
Read now
H. Mani, K. Kirchmayr, C. Kläffling, M. Schindewolf, B. Luxembourg, B. Linnemann & E. Lindhoff-Last. (2004) Influence of blood collection techniques on platelet function. Platelets 15:5, pages 315-318.
Read now
Read now
Articles from other publishers (99)
Gordon Ogweno & Edwin Kimathi. 2023. HIV Treatment - New Developments [Working Title]. HIV Treatment - New Developments [Working Title].
Simon Davidson. 2023. Hemostasis and Thrombosis. Hemostasis and Thrombosis
381
402
.
Dr. Matthieu Perier, Dr. Gabriel Seret, Dr. Florent Huang, Dr. Jean- Guillaume Dillinger, Pr. Patrick Henry, Pr. Ludovic Drouet & Dr. Hakim Benamer. (2021) Résistance à l'aspirine : l'ennemi de mon ami est mon ennemi. Annales de Cardiologie et d'Angéiologie 70:6, pages 401-409.
Crossref
Crossref
Diego Arauna, Francisco García, Leocadio Rodríguez-Mañas, Jaume Marrugat, Claudia Sáez, Marcelo Alarcón, Sergio Wehinger, Yolanda Espinosa-Parrilla, Iván Palomo & Eduardo Fuentes. (2020) Older adults with frailty syndrome present an altered platelet function and an increased level of circulating oxidative stress and mitochondrial dysfunction biomarker GDF-15. Free Radical Biology and Medicine 149, pages 64-71.
Crossref
Crossref
Dermot Cox. (2019) Anti‐platelet agents: past, present and future. ISBT Science Series 15:1, pages 131-141.
Crossref
Crossref
K. Yu. Lukianets & I. Yu. Pchelin. (2020) ACETYLSALICYLIC ACID RESISTANCE: RISK FACTORS, MECHANISMS, DIAGNOSTIC TESTS. Juvenis Scientia 6:2, pages 16-34.
Crossref
Crossref
Márcia Ferreira, Margarida Freitas-Silva, Joana Assis, Ricardo Pinto, José P Nunes & Rui Medeiros. (2020) The emergent phenomenon of aspirin resistance: insights from genetic association studies. Pharmacogenomics 21:2, pages 125-140.
Crossref
Crossref
Ahmed S. Yassin, Hossam Abubakar, Tushar Mishra, Ahmed Subahi, Melanie Hartman, Abdelrahman Ahmed, Walid Ibrahim, Manmohan Singh & Mohit Pahuja. (2019) Aspirin Resistance: Cardiovascular Risk Game Changer. American Journal of Therapeutics 26:5, pages e593-e599.
Crossref
Crossref
Jun Yong, Shaomei Zhang, Yan Gao, Wenchen Guo, Peixia Shi & Qinglin Zhou. (2018) Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients. Experimental and Therapeutic Medicine.
Crossref
Crossref
Erica S. Westphal, Caitlin Wisniewski, Michelle Rainka, Nicholas M. Smith, Vernice Bates & Fran M. Gengo. (2018) The Development of an In Vitro Assay for the Prospective Determination of Aspirin Sensitivity. The Journal of Clinical Pharmacology 58:9, pages 1150-1156.
Crossref
Crossref
Erica S. Westphal, Michelle Rainka, Michelle Amsler, Traci Aladeen, Caitlin Wisniewski, Vernice Bates & Fran M. Gengo. (2018) Prospective Determination of Aspirin Sensitivity in Patients Resistant to Low Dose Aspirin: A Proof of Concept Study. The Journal of Clinical Pharmacology 58:9, pages 1157-1163.
Crossref
Crossref
Kate Navaratnam, Ana Alfirevic, Andrea Jorgensen & Zarko Alfirevic. (2018) Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 221, pages 144-150.
Crossref
Crossref
Kate Navaratnam, Zarko Alfirevic, Munir Pirmohamed & Ana Alfirevic. (2017) How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?. European Journal of Obstetrics & Gynecology and Reproductive Biology 219, pages 1-9.
Crossref
Crossref
J. M. Haines, P. M. Lee, R. M. Hegedus, J. K. Hwang & M. H. Court. (2017)
Establishment of reference ranges and evaluation of
in vitro
concentration-dependent platelet inhibition by acetylsalicylic acid for multiple electrode impedance aggregometry in healthy dogs
. Journal of Veterinary Pharmacology and Therapeutics.
Crossref
Crossref
Mei Xue, Xuesong Yang, Lin Yang, Na Kou, Yu Miao, Mingming Wang, Junhua Ren & Quanli Zhao. (2017) rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-8.
Crossref
Crossref
Lauren E. Walker, Anna Stewart & Sir Munir Pirmohamed. 2017. Stroke Genetics. Stroke Genetics
327
410
.
J. Thomason, K. Lunsford & A. Mackin. (2016) Anti-platelet therapy in small animal medicine. Journal of Veterinary Pharmacology and Therapeutics 39:4, pages 318-335.
Crossref
Crossref
K Navaratnam, A Alfirevic & Z Alfirevic. (2016) Low dose aspirin and pregnancy: how important is aspirin resistance?. BJOG: An International Journal of Obstetrics & Gynaecology 123:9, pages 1481-1487.
Crossref
Crossref
Karsten Schrör. 2016. Acetylsalicylic Acid. Acetylsalicylic Acid
263
446
.
Fran Gengo, Erica S. Westphal, Michelle M. Rainka, Maria Janda, Matthew J. Robson, J. Maurice Hourihane & Vernice Bates. (2015) Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg. The Journal of Clinical Pharmacology 56:4, pages 414-421.
Crossref
Crossref
Jillian M. Haines, John M. Thomason, Eileen C. Seage, Robert W. Wills, Camilo Bulla, Kari V. Lunsford & Andrew J. Mackin. (2016) In vitro and in vivo assessment of platelet function in healthy dogs during administration of a low-dose aspirin regimen. American Journal of Veterinary Research 77:2, pages 174-185.
Crossref
Crossref
Chunjiang Tan, Xiao Lu, Wenlie Chen & Songming Chen. (2015) Serum ubiquitin via CXC chemokine receptor 4 triggered cyclooxygenase-1 ubiquitination possibly involved in the pathogenesis of aspirin resistance. Clinical Hemorheology and Microcirculation 61:1, pages 59-81.
Crossref
Crossref
Mate Petricevic, Tomislav Kopjar, Hrvoje Gasparovic, Davor Milicic, Lucija Svetina, Boris Zdilar, Marko Boban, Martina Zrno Mihaljevic & Bojan Biocina. (2014) Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639). Journal of Thrombosis and Thrombolysis 39:4, pages 522-531.
Crossref
Crossref
Ai-ju Liu, Hui-qin Li, Ji-huang Li, Yuan-yuan Wang, Dong Chen, Yan Wang & Guo-qing Zheng. (2014) Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-16.
Crossref
Crossref
Christopher N. Floyd & Albert Ferro. (2014) Mechanisms of aspirin resistance. Pharmacology & Therapeutics 141:1, pages 69-78.
Crossref
Crossref
Hrvoje Gasparovic, Mate Petricevic & Bojan Biocina. (2013) Impact and Diagnosis of Antiplatelet Therapy Resistance in Patients Undergoing Cardiac Surgery. Drug Development Research 74:7, pages 492-504.
Crossref
Crossref
Ashraf El-Mitwalli, Hanan Azzam, Mohammad Abu-Hegazy, Mohamed Gomaa & Yasser Wasel. (2013) Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia. Clinical Neurology and Neurosurgery 115:7, pages 944-947.
Crossref
Crossref
Payam Fallahi, Richard Katz, Ian Toma, Ranyang Li, Jonathan Reiner, Kiersten VanHouten, Larry Carpio, Lorraine Marshall, Yi Lian, Sujata Bupp, Sidney W. Fu, Frederick Rickles, David Leitenberg, Yinglei Lai, Babette B. Weksler, Frederik Rebling, Zhaoqing Yang & Timothy A. McCaffrey. (2013) Aspirin insensitive thrombophilia: Transcript profiling of blood identifies platelet abnormalities and HLA restriction. Gene 520:2, pages 131-138.
Crossref
Crossref
Afshin A. Divani, Nicole D. Zantek, Afshin Borhani-Haghighi & Gundu H. R. Rao. (2012) Antiplatelet Therapy. Clinical and Applied Thrombosis/Hemostasis 19:1, pages 5-18.
Crossref
Crossref
Paul A. Gurbel & Udaya S. Tantry. 2013. Platelets. Platelets
603
633
.
Lauren E. Walker, Anna Stewart & Munir Pirmohamed. 2013. Stroke Genetics. Stroke Genetics
223
297
.
Alf‐Åge R. Pettersen, Ingebjørg Seljeflot, Michael Abdelnoor & Harald Arnesen. (2012) High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial). Journal of the American Heart Association 1:3.
Crossref
Crossref
Gundu H. R. Rao & Jawad Fareed. (2012) Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations. Thrombosis 2012, pages 1-9.
Crossref
Crossref
Refaee M. Ahmed, Mousa S. Moustafa, Khater M. Shawky, Nabih E. Samir, Hassan A. Nour El Din & El Banouby M. Hassan. (2012) Obesity: Is It a Major Risk for Developing Aspirin Resistance in Older Adults?. Journal of the American Geriatrics Society 60:1, pages 180-182.
Crossref
Crossref
B. van der Loo, J. Braun & R. Koppensteiner. (2011) On-treatment Function Testing of Platelets and Long-term Outcome of Patients with Peripheral Arterial Disease Undergoing Transluminal Angioplasty. European Journal of Vascular and Endovascular Surgery 42:6, pages 809-816.
Crossref
Crossref
Abdalla Awidi, Akram Saleh, Manar Dweik, Baraah Kailani, Mohammed Abu-Fara, Rinad Nabulsi & Abdulbari Bener. (2010) Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: a prospective study. Heart and Vessels 26:5, pages 516-522.
Crossref
Crossref
Richard FitzGerald & Munir Pirmohamed. (2011) Aspirin resistance: Effect of clinical, biochemical and genetic factors. Pharmacology & Therapeutics 130:2, pages 213-225.
Crossref
Crossref
Meltem Refiker. (2011) Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting surgery. American Heart Journal 161:5, pages e25.
Crossref
Crossref
David M. Greer. (2010) Aspirin and Antiplatelet Agent Resistance. CNS Drugs 24:12, pages 1027-1040.
Crossref
Crossref
E. SCHWEDHELM, A. BIEREND, R. MAAS, R. TRINKS, G.D. KOM, D. TSIKAS & R.H. BÖGER. (2010) Redox‐generated isoprostanes are associated with residual platelet activity in aspirin‐treated patients with stable coronary heart disease. Journal of Thrombosis and Haemostasis 8:12, pages 2662-2670.
Crossref
Crossref
A. PEACE, M. MCCALL, T. TEDESCO, D. KENNY, R.M. CONROY, D. FOLEY & D. COX. (2010) The role of weight and enteric coating on aspirin response in cardiovascular patients. Journal of Thrombosis and Haemostasis 8:10, pages 2323-2325.
Crossref
Crossref
Patrick Henry & Ludovic Drouet. (2010) Résistances aux antiagrégants plaquettaires. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2010:187, pages 14-21.
Crossref
Crossref
Faouzi Addad, Tahar Chakroun, Fatma Abderazek, Mohamed Ben-Farhat, Sonia Hamdi, Zohra Dridi, Habib Gamra, Mohsen Hassine, Meyer M. Samama & Ismail Elalamy. (2009) Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. Journal of Thrombosis and Thrombolysis 29:1, pages 108-113.
Crossref
Crossref
J. Kempfert, K. Anger, A. Rastan, S. Krabbes, S. Lehmann, J. Garbade, M. Sauer, T. Walther, S. Dhein & F. W. Mohr. (2009) Postoperative development of aspirin resistance following coronary artery bypass. European Journal of Clinical Investigation 39:9, pages 769-774.
Crossref
Crossref
Jiabei Li, Zhao Jian, Lan Huang, Hui Guo, Junfu Huang, Dehui Qian, Weiling Fu, Aimin Li & Yaoming Song. (2009) Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Biomedicine & Pharmacotherapy 63:8, pages 608-612.
Crossref
Crossref
F. M. Pulcinelli, L. M. Biasucci, S. Riondino, S. Giubilato, A. Leo, L. Di Renzo, E. Trifiro, T. Mattiello, D. Pitocco, G. Liuzzo, G. Ghirlanda & F. Crea. (2009) COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. European Heart Journal 30:10, pages 1279-1286.
Crossref
Crossref
Joseph M. Sweeny, Diana A. Gorog & Valentin Fuster. (2009) Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements. Nature Reviews Cardiology 6:4, pages 273-282.
Crossref
Crossref
J. B. Li, H. M. Dong, Z. Jian, X. J. Wu, X. H. Zhao, S. Y. Yu & L. Huang. (2009) Responsiveness to aspirin in patients with unstable angina pectoris by whole blood aggregometry. International Journal of Clinical Practice 63:3, pages 407-416.
Crossref
Crossref
P.L. Bernstein, B.F. Jacobson, M.D. Connor & P.J. Becker. (2009) Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events. Journal of the Neurological Sciences 277:1-2, pages 80-82.
Crossref
Crossref
Karsten Schrör. 2008. Acetylsalicylic Acid. Acetylsalicylic Acid
223
365
.
Dana Védy, Marc Schapira & Anne Angelillo-Scherrer. 2010. Uncommon Causes of Stroke. Uncommon Causes of Stroke
283
300
.
W. Kuliczkowski, A. Witkowski, L. Polonski, C. Watala, K. Filipiak, A. Budaj, J. Golanski, D. Sitkiewicz, J. Pregowski, J. Gorski, M. Zembala, G. Opolski, K. Huber, H. Arnesen, S. D. Kristensen & R. De Caterina. (2008) Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. European Heart Journal 30:4, pages 426-435.
Crossref
Crossref
Dietmar Trenk & Franz-Josef Neumann. (2008) Aspirin Resistance. Journal of the American College of Cardiology 52:9, pages 740-742.
Crossref
Crossref
Oyku Gulmez, Aylin Yildirir, Gamze Kaynar, Didem Konas, Alp Aydinalp, Cagatay Ertan, Bulent Ozin & Haldun Muderrisoglu. (2007) Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions. Journal of Thrombosis and Thrombolysis 25:3, pages 239-246.
Crossref
Crossref
M.C. García Cubero, D. Rodríguez Morales & B. Burgoa Alcalaya. (2008) Resistencia al ácido acetilsalicílico y sus repercusiones clínicas. SEMERGEN - Medicina de Familia 34:5, pages 244-248.
Crossref
Crossref
Kwok F.J. Ng, Jean-Claude Lawmin, Carina C.F. Li, Suk F. Tsang, Wai M. Tang & Kwong Y. Chiu. (2008) Comprehensive Preoperative Evaluation of Platelet Function in Total Knee Arthroplasty Patients Taking Diclofenac. The Journal of Arthroplasty 23:3, pages 424-430.
Crossref
Crossref
Lisa C. Heistein, William A. Scott, Thomas M. Zellers, David E. Fixler, Claudio Ramaciotti, Janna M. Journeycake & Matthew S. Lemler. (2007) Aspirin Resistance in Children with Heart Disease at Risk for Thromboembolism: Prevalence and Possible Mechanisms. Pediatric Cardiology 29:2, pages 285-291.
Crossref
Crossref
T. HOHLFELD, N. ZIMMERMANN, A.‐A. WEBER, G. JESSEN, H. WEBER, K. SCHRÖR, H.‐D. HÖLTJE & R. EBEL. (2008) Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis. Journal of Thrombosis and Haemostasis 6:1, pages 166-173.
Crossref
Crossref
Jose F. Roldan & Robin L. Brey. 2008. Uncommon Causes of Stroke. Uncommon Causes of Stroke
263
274
.
G.I. Adebayo, J. Williams & S. Healy. (2007) Aspirin esterase activity — Evidence for skewed distribution in healthy volunteers. European Journal of Internal Medicine 18:4, pages 299-303.
Crossref
Crossref
Boris T Ivandic, Evangelos Giannitsis, Philipp Schlick, Peter Staritz, Hugo A Katus & Thomas Hohlfeld. (2007) Determination of Aspirin Responsiveness by Use of Whole Blood Platelet Aggregometry. Clinical Chemistry 53:4, pages 614-619.
Crossref
Crossref
Marcel M.C. Hovens, Jaapjan D. Snoep, Jeroen C.J. Eikenboom, Johanna G. van der Bom, Bart J.A. Mertens & Menno V. Huisman. (2007) Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review. American Heart Journal 153:2, pages 175-181.
Crossref
Crossref
Oyku Gulmez, Aylin Yildirir, Ugur Bal, Necibe Didem Konas, Alp Aydinalp, Ozlem Demir, Ilyas Atar, Cagatay Ertan, Bulent Ozin & Haldun Muderrisoglu. (2007) Assessment of biochemical aspirin resistance at rest and immediately after exercise testing. Blood Coagulation & Fibrinolysis 18:1, pages 9-13.
Crossref
Crossref
Paul Harrison, A.L. FrelingerIIIIII, Mark I. Furman & Alan D. Michelson. (2007) Measuring antiplatelet drug effects in the laboratory. Thrombosis Research 120:3, pages 323-336.
Crossref
Crossref
Shinichi Takahashi, Miho Ushida, Risa Komine, Aya Shimizu, Toshihiro Uchida, Hiroaki Ishihara, Toshiro Shibano, Gentaro Watanabe, Yasuo Ikeda & Mitsuru Murata. (2007) Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thrombosis Research 119:4, pages 517-524.
Crossref
Crossref
Eli I. Lev, Ramanujam S. Ramabadran, Sasidhar Guthikonda, Rajnikant Patel, Amanda Kleiman, Juan F. Granada, Timothy DeLao & Neal S. Kleiman. (2007) Effect of Ranitidine on the Antiplatelet Effects of Aspirin in Healthy Human Subjects. The American Journal of Cardiology 99:1, pages 124-128.
Crossref
Crossref
Richard C. Becker. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
339
369
.
Paul Harrison & David Keeling. 2007. Platelets. Platelets
445
474
.
Thach N. Nguyen, Tan Huay Cheem, Bikash Agarwal, Rupesh Shah, James Nguyen & Nguyen Lan Viet. 2007. Management of Complex Cardiovascular Problems. Management of Complex Cardiovascular Problems
1
18
.
Xi Cheng, Wai-Hong Chen & Daniel I. Simon. (2006) Aspirin Resistance or Variable Response or Both?. The American Journal of Cardiology 98:10, pages S11-S17.
Crossref
Crossref
Karsten Schrör, T. Hohlfeld & A.-A. Weber. (2006) Aspirin resistance – does it clinically matter?. Clinical Research in Cardiology 95:10, pages 505-510.
Crossref
Crossref
Leszek Markuszewski, Marcin Rosiak, Jacek Golanski, Jacek Rysz, Magdalena Spychalska & Cezary Watala. (2006) Reduced Blood Platelet Sensitivity to Aspirin in Coronary Artery Disease: Are Dyslipidaemia and Inflammatory States Possible Factors Predisposing to Sub-optimal Platelet Response to Aspirin?. Basic & Clinical Pharmacology & Toxicology 98:5, pages 503-509.
Crossref
Crossref
Amgad N. Makaryus. (2006) Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease. Clinical Cardiology 29:4, pages 144-148.
Crossref
Crossref
Karsten Schrör, Artur-Aron Weber & Thomas Hohlfeld. (2006) Aspirin “resistance”. Blood Cells, Molecules, and Diseases 36:2, pages 171-176.
Crossref
Crossref
F.M. PULCINELLI & S. RIONDINO. (2006) More on: aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm. Journal of Thrombosis and Haemostasis 4:2, pages 485-487.
Crossref
Crossref
Graeme J Hankey & John W Eikelboom. (2006) Aspirin resistance. The Lancet 367:9510, pages 606-617.
Crossref
Crossref
Thomas Hohlfeld. (2006) Aspirin-Resistenz / Aspirin resistance. LaboratoriumsMedizin 30:5, pages 302-309.
Crossref
Crossref
T. Lecompte & M. Toussaint-Hacquard. (2006) Inhibiteurs du fonctionnement plaquettaire. EMC - Hématologie 1:1, pages 1-12.
Crossref
Crossref
Catharina Borna, Eduardo Lazarowski, Catharina van Heusden, Hans Öhlin & David Erlinge. (2005) Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thrombosis Journal 3:1.
Crossref
Crossref
F.M. PULCINELLI, S. RIONDINO, A. CELESTINI, P. PIGNATELLI, E. TRIFIRÒ, L. DI RENZO & F. VIOLI. (2005) Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin. Journal of Thrombosis and Haemostasis 3:12, pages 2784-2789.
Crossref
Crossref
Tammy L. Burns, Aryan N. Mooss & Daniel E. Hilleman. (2005) Antiplatelet Drug Resistance: Not Ready for Prime Time. Pharmacotherapy 25:11, pages 1621-1628.
Crossref
Crossref
Tina Svenstrup Poulsen, Søren Risom Kristensen, Dan Atar & Hans Mickley. (2005) A Critical Appraisal of the Phenomenon of Aspirin Resistance. Cardiology 104:2, pages 83-91.
Crossref
Crossref
Jacek Gola??ski, Stefan Ch??opicki, Ryszard Gola??ski, Peter Gresner, Alicja Iwaszkiewicz & Cezary Watala. (2005) Resistance to Aspirin in Patients After Coronary Artery Bypass Grafting Is Transient. Therapeutic Drug Monitoring 27:4, pages 484-490.
Crossref
Crossref
K. Schrör. (2005) HämostaseologieHaemostaseology. Der Internist 46:8, pages 873-881.
Crossref
Crossref
Christopher P. Martin & Robert L. Talbert. (2005) Aspirin Resistance: An Evaluation of Current Evidence and Measurement Methods. Pharmacotherapy 25:7, pages 942-953.
Crossref
Crossref
T. Lecompte & M. Toussaint-Hacquard. (2005) Inhibiteurs du fonctionnement plaquettaire. EMC - Hématologie 2:1, pages 35-51.
Crossref
Crossref
Enrique Bernal Morell & José Sabán Ruiz. (2005) Resistencia a la aspirina. Medicina Clínica 124:1, pages 30-36.
Crossref
Crossref
Klaus-Werner von Pape, Gerhard Strupp, Tassilo Bonzel & Jürgen Bohner. (2017) Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction. Thrombosis and Haemostasis 94:10, pages 889-891.
Crossref
Crossref
Mehmet Birhan Yilmaz, Yucel Balbay, Vedat Caldir, Selime Ayaz, Yesim Guray, Umit Guray & Sule Korkmaz. (2005) Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thrombosis Research 115:1-2, pages 25-29.
Crossref
Crossref
C. H. Hennekens. (2004) Terms and Conditions: Semantic Complexity and Aspirin Resistance. Circulation 110:12, pages 1706-1708.
Crossref
Crossref
S Wong, M Appleberg, C.M Ward & D.R Lewis. (2004) Aspirin Resistance in Cardiovascular Disease: A Review. European Journal of Vascular and Endovascular Surgery 27:5, pages 456-465.
Crossref
Crossref
Jacek Golański, Marek Nocuń, Marcin Różalski, Wojciech Drygas & Cezary Watała. (2004) An in vitro model for the detection of reduced platelet sensitivity to acetylsalicylic acid. Blood Coagulation & Fibrinolysis 15:2, pages 187-195.
Crossref
Crossref
Mark J. AlbertsDeborah L. BergmanElise MolnerBorko D. JovanovicIssei UshiwataJun Teruya. (2004) Antiplatelet Effect of Aspirin in Patients With Cerebrovascular Disease. Stroke 35:1, pages 175-178.
Crossref
Crossref
Cezary Watala, Jacek Golanski, Justyna Pluta, Magdalena Boncler, Marcin Rozalski, Bogusława Luzak, Anna Kropiwnicka & Józef Drzewoski. (2004) Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)—its relation to metabolic control. Thrombosis Research 113:2, pages 101-113.
Crossref
Crossref
Lidija Covic, Suzanne Jacques & Athan Kuliopulos. (2003) Reply to “Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin”. Nature Medicine 9:12, pages 1447-1448.
Crossref
Crossref
Jan Julius Stampfuss, Karsten Schrör & Artur-Aron Weber. (2003) Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin. Nature Medicine 9:12, pages 1447-1447.
Crossref
Crossref
N. ZimmermannA. WenkU. KimP. KienzleA.-A. WeberE. GamsK. SchrörT. Hohlfeld. (2003) Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery. Circulation 108:5, pages 542-547.
Crossref
Crossref
M. Cattaneo. (2003) The platelet P2Y receptors as targets for new antithrombotic drugs. Journal of Thrombosis and Haemostasis 1:6, pages 1133-1135.
Crossref
Crossref
Nathalie Hézard, Damien Metz, Pierre Nazeyrollas, Chantal Droullé, Gérard Potron & Philippe Nguyen. (2002) PFA-100™ and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?. Thrombosis Research 108:1, pages 43-47.
Crossref
Crossref